Skip to main content

Table 1 Follow-up of body weights and glucose concentrations

From: Caloric restriction or telmisartan control dyslipidemia and nephropathy in obese diabetic Zücker rats

 

Body weight (g)

 

Glucose (mg/dL)

 

Animal

10

19

Weight increase

10

19

Glucose increase

Z

330 ± 23

517 ± 34

187 ± 35

150 ± 16

188 ± 78

38 ± 72

ZDFV

356 ± 22

433 ± 35*

76 ± 22*

201 ± 96

593 ± 63*

416 ± 103*

ZDFT

360 ± 14

480 ± 68

119 ± 62

223 ± 130

478 ± 115

218 ± 121

ZDFD

337 ± 13

495 ± 15

158 ± 14

146 ± 23

360 ± 119

213 ± 130

  1. Differences between the experimental time-points (weeks 10 and 19) in the non-diabetic and diabetic obese rats. Data are shown as mean ± SD. Significant differences *p < 0.05 vs Zücker, p < 0.05 vs ZDFV. The greater weight increase was seen in the non-diabetic rats (Z) and the fatty-diabetic animals subjected to caloric restriction (ZDFD). Conversely, in the vehicle group (ZDFV), we saw a trend to a slower weight gain but the most marked increase in hyperglycaemia over time.